Literature DB >> 22975535

Significance of electrocardiographic right ventricular hypertrophy in patients with pulmonary hypertension with or without right ventricular systolic dysfunction.

Toshiyuki Nagai1, Shun Kohsaka, Mitsushige Murata, Shigeo Okuda, Toshihisa Anzai, Keiichi Fukuda, Toru Satoh.   

Abstract

OBJECTIVE: We sought to determine the value of electrocardiographic right ventricular hypertrophy (ECG-RVH) in pulmonary hypertension (PH) patients with right ventricular systolic dysfunction defined by cardiac magnetic resonance (CMR-RVSD). PATIENTS: A total of 31 consecutive patients with PH with a mean pulmonary arterial pressure of >25 mmHg underwent both ECG and CMR studies. Patients were divided into 2 groups according to the presence of RVSD, defined as a RV ejection fraction <35%. Logistic regression modeling was performed to define the association between ECG-RVH and CMR-RVSD.
RESULTS: About half of the patients had RVSD (n=15 ; 48%). The R to S wave ratio (p=0.01) or incidence of qR pattern (p=0.002) in lead V(1) was significantly greater in patients with PH complicated by RVSD than in those without RVSD. These 2 patterns were significant predictors of RVSD [odds ratio (OR), 19.3 for qR; OR, 14.0 for R/S>1] and when each of these ECG findings was assigned with a point proportional to OR (score of 2 for qR in lead V(1) and score of 1 for R/S>1 in lead V(1)), the incidence of RVSD increased by the total ECG score.
CONCLUSION: The combination of ECG-RVH findings, especially in lead V(1), predicts the presence of RVSD defined by CMR. ECG might be a useful tool for estimating the presence of RVSD in patients with PH.

Entities:  

Mesh:

Year:  2012        PMID: 22975535     DOI: 10.2169/internalmedicine.51.7731

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Utility of the amplitude of RV1+SV5/6 in assessment of pulmonary hypertension.

Authors:  Sachiyo Igata; Nobuhiro Tahara; Yoichi Sugiyama; Munehisa Bekki; Jun Kumanomido; Atsuko Tahara; Akihiro Honda; Shoko Maeda; Kazutaka Nashiki; Tomohisa Nakamura; Jiahui Sun; Toshi Abe; Yoshihiro Fukumoto
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

2.  The Relationship between Electrocardiographic Changes and Prognostic Factors in Severely Symptomatic Pulmonary Hypertension.

Authors:  Seyed Reza Seyyedi; Babak Sharif-Kashani; Makan Sadr; Mandana Chitsazan; Majid Malekmohammad; Atefeh Abedini; Fateme Monjazebi; Farah Naghashzadeh
Journal:  Tanaffos       Date:  2019-01

3.  Prevalence and predictive value of electrocardiographic abnormalities in pulmonary hypertension: evidence from the Pan-African Pulmonary Hypertension Cohort (PAPUCO) study.

Authors:  Irina Balieva; Anastase Dzudie; Friedrich Thienemann; Ana O Mocumbi; Kamilu Karaye; Mahmoud U Sani; Okechukwu S Ogah; Adriaan A Voors; Andre Pascal Kengne; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2017-10-11       Impact factor: 1.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.